MOTS-c peptide: what it is and why its mitochondrial origin matters
7 min read · Updated September 2026 · MY PEPTIDES Research Team
Key facts
MOTS-c is a 16-amino-acid peptide with an unusual address: its sequence sits inside the 12S rRNA region of mitochondrial DNA rather than in the nuclear genome, placing it in a small class called mitochondrial-derived peptides. That origin is the hook, direct evidence that mitochondria encode signaling molecules of their own instead of only following instructions from the nucleus. Labs use it to study mitochondrial-to-nuclear communication, cellular energy sensing and metabolic regulation, with experiments most often tracking AMPK activation, metabolic gene expression and stress-responsive signaling. It is frequently studied next to NAD+, since the two sit in the same metabolic-research workflows. Outcomes shift with concentration, exposure time and model system, and culture-dish results do not carry over cleanly to whole organisms. For US laboratories, MOTS-c ships pre-mixed as a solution with a batch-specific Certificate of Analysis, synthesized in our UK laboratory and verified in the US before dispatch, delivered cold-chain next business day, priced in US dollars, and held refrigerated at 2-8°C. Supplied only for in-vitro laboratory research, not for use in humans or animals, with no therapeutic claims, and it has not been evaluated by the FDA.
MOTS-c is a 16-amino-acid peptide, and what sets it apart is where its sequence lives: inside the 12S rRNA region of mitochondrial DNA, not the nuclear genome. That places it in a small group called mitochondrial-derived peptides (MDPs), and that origin is exactly why researchers pay attention to it.
For laboratory research only. This page explains what MOTS-c is and what the published literature examines. It gives no dosing or administration guidance, offers no instructions for use in people or animals, makes no therapeutic claims, and describes a compound that has not been evaluated by the FDA.
Why the origin is unusual
Reach for almost any protein in a human cell and its blueprint sits in nuclear DNA. Mitochondria do keep a small genome of their own, a holdover from their beginnings as free-living bacteria, but the long-standing assumption was that it coded only for the parts a mitochondrion needs to run its own respiratory machinery.
Mitochondrial-derived peptides complicate that story. MOTS-c is encoded by mitochondrial DNA yet appears to act beyond the mitochondrion, reaching as far as nuclear gene expression. In other words, the signal runs opposite to the textbook picture: not the nucleus directing the mitochondria, but the mitochondria signaling back to the rest of the cell. That reversal is the appeal. MOTS-c gives researchers a handle on mitochondrial-to-nuclear communication, a relatively new field, and a defined synthetic peptide is far more workable than trying to catch endogenous signaling in the act.
What the research actually examines
Before the benefit lists, it is worth separating what the primary literature examines from what gets claimed downstream. The published work is in-vitro and preclinical, in cultured cells and animal models, and it does not establish outcomes in people. It tends to settle on three linked areas:
- Energy sensing, above all AMPK activation. AMPK is the cell's master energy gauge, reading the AMP-to-ATP ratio, and it is the pathway MOTS-c studies return to most often.
- Metabolic gene regulation, shifts in the expression of genes handling glucose and lipids, measured in cultured cells.
- Stress-responsive signaling, how the peptide behaves when cells are pushed into metabolic or oxidative stress.
As with any in-vitro literature, the findings depend heavily on concentration, how long the exposure runs, and the model in use. Observations from culture do not translate straight to whole organisms, and the area is still exploratory rather than settled. The sources below are a reasonable map of where the field stands.
Why MOTS-c and NAD+ turn up together
MOTS-c is often run in the same workflows as NAD+, and the reason is mechanistic rather than coincidental. NAD+ is the hub redox cofactor of cellular metabolism and a substrate for the sirtuins, and the AMPK and NAD+/sirtuin systems are wired into each other as energy sensors. A lab digging into cellular energy regulation usually ends up looking at both.
Chemically, though, they are unrelated: NAD+ is a dinucleotide, not a peptide in any sense. Our NAD+ guide lays out that distinction, and what research peptides are sets the wider context.
Supply and format
We list MOTS-c as a ready-mixed solution rather than a lyophilized powder, so there is nothing to reconstitute. Each batch is documented by its own Certificate of Analysis recording identity and HPLC purity. To work out the concentration of a vial, the peptide calculator handles the arithmetic.
How MOTS-c ships in the United States
For US laboratories, MOTS-c is supplied as a pre-mixed solution prepared under controlled conditions, HPLC-verified, with a batch-specific Certificate of Analysis that reports purity by HPLC and identity by mass spectrometry. Every batch is synthesized in our own UK laboratory, and each US lot is tested again in a US laboratory before it ships, so the material is made in one place and confirmed a second time close to you. Orders are dispatched cold-chain from the warehouse that serves the United States, with tracked delivery across the country next business day, priced in US dollars and payable by Visa, Mastercard or Apple Pay. Store it refrigerated at 2-8°C on arrival, not frozen.
What MOTS-c is not
- It is not an approved medicine anywhere, has not been evaluated by the FDA, and is not supplied for human or veterinary use.
- It is not a metabolic treatment. The exercise and metabolism headlines around MOTS-c come from preclinical work, not from clinical outcomes.
- It is not interchangeable with NAD+. The two share research workflows but are different classes of molecule.
Dosing and administration
We do not publish dosing, reconstitution-for-use or administration guidance for MOTS-c. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use, so quantity guidance aimed at a person would be inconsistent with what is supplied. Experimental concentrations are specific to the model and endpoint and belong in the primary literature.
Related reading
MOTS-c
Available now from MY PEPTIDES — 99%+ purity, COA with every order, fast US shipping.
Frequently asked questions
- What is MOTS-c peptide?
- MOTS-c is a 16-amino-acid mitochondrial-derived peptide, encoded within the 12S rRNA region of mitochondrial DNA rather than in the nuclear genome. Labs use it to study mitochondrial-to-nuclear signaling, cellular energy sensing and metabolic regulation. For in-vitro research use only.
- What does MOTS-c stand for?
- Mitochondrial Open reading frame of the Twelve S rRNA type-c. The name points to where in the mitochondrial genome the sequence sits, the 12S ribosomal RNA region.
- What makes a mitochondrial-derived peptide different?
- Nearly every cellular protein is encoded by nuclear DNA. Mitochondrial-derived peptides are encoded by the mitochondrion's own small genome and appear to act outside it, reaching even nuclear gene expression, signaling that travels from the mitochondria outward rather than inward.
- Why is MOTS-c studied alongside NAD+?
- Both sit inside cellular energy metabolism. AMPK, the pathway MOTS-c research examines most, and the NAD+/sirtuin axis are interlocking energy-sensing systems, so a lab studying metabolic regulation frequently has cause to look at each. They stay chemically unrelated: NAD+ is a dinucleotide, not a peptide.
- How quickly does MOTS-c ship in the US?
- Orders are dispatched cold-chain from the warehouse that serves the United States, with tracked delivery across the country next business day. MOTS-c is priced in US dollars and payable by Visa, Mastercard or Apple Pay, and it ships pre-mixed, so there is no powder to reconstitute.
- Is MOTS-c FDA-approved?
- No. MOTS-c is not an approved drug in the United States and has not been evaluated by the FDA. It is supplied strictly for in-vitro laboratory research and is not for human or veterinary use.
- How should MOTS-c be stored?
- Keep it refrigerated at 2-8°C, not frozen. We supply it as a ready-mixed solution rather than a freeze-dried powder, so no reconstitution step and no bacteriostatic water are needed.